X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (46311) 46311
Patent (36461) 36461
Publication (6482) 6482
Book Review (583) 583
Book Chapter (355) 355
Newsletter (295) 295
Book / eBook (183) 183
Newspaper Article (121) 121
Conference Proceeding (118) 118
Magazine Article (57) 57
Dissertation (22) 22
Data Set (16) 16
Transcript (14) 14
Trade Publication Article (11) 11
Web Resource (9) 9
Government Document (5) 5
Reference (3) 3
Streaming Video (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nucleotides (39803) 39803
nucleic acids (37418) 37418
chemistry (37316) 37316
nucleosides (37089) 37089
organic chemistry (36789) 36789
sugars (36582) 36582
derivatives thereof (36461) 36461
metallurgy (36461) 36461
human necessities (35439) 35439
hygiene (35369) 35369
medical or veterinary science (35341) 35341
preparations for medical, dental, or toilet purposes (34805) 34805
humans (32338) 32338
specific therapeutic activity of chemical compounds ormedicinal preparations (32010) 32010
index medicus (30795) 30795
microbiology (18658) 18658
biochemistry (18372) 18372
enzymology (16640) 16640
wine (16527) 16527
beer (16522) 16522
vinegar (16520) 16520
mutation or genetic engineering (16519) 16519
spirits (16519) 16519
male (15681) 15681
female (15512) 15512
culture media (14180) 14180
compositions thereof (14119) 14119
microorganisms or enzymes (14119) 14119
propagating, preserving or maintaining microorganisms (14119) 14119
animals (11685) 11685
peptides (11453) 11453
polymorphism, single nucleotide (11320) 11320
genetic aspects (10113) 10113
middle aged (9662) 9662
adult (8933) 8933
heterocyclic compounds (8039) 8039
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (7823) 7823
research (7794) 7794
genotype (7254) 7254
pharmacology & pharmacy (7062) 7062
analysis (6994) 6994
genes (6709) 6709
aged (6547) 6547
cancer (6377) 6377
general tagging of cross-sectional technologies spanning over several sections of the ipc (5942) 5942
general tagging of new technological developments (5942) 5942
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (5942) 5942
physics (5864) 5864
testing (5616) 5616
measuring (5566) 5566
investigating or analysing materials by determining theirchemical or physical properties (5554) 5554
compositions or test papers therefor (5516) 5516
condition-responsive control in microbiological orenzymological processes (5516) 5516
measuring or testing processes involving enzymes, nucleicacids or microorganisms (5516) 5516
processes of preparing such compositions (5516) 5516
single nucleotide polymorphisms (5393) 5393
gene expression (5315) 5315
mutation (5267) 5267
genetics (5242) 5242
research article (5238) 5238
oncology (5176) 5176
medicine (5090) 5090
proteins (5057) 5057
article (5015) 5015
genomes (5001) 5001
genomics (4845) 4845
multidisciplinary sciences (4614) 4614
health aspects (4607) 4607
biochemistry & molecular biology (4587) 4587
genetics & heredity (4587) 4587
expression (4515) 4515
risk factors (4484) 4484
mice (4198) 4198
dna (4123) 4123
deoxyribonucleic acid--dna (4054) 4054
genetic predisposition to disease (4041) 4041
single-nucleotide polymorphism (3923) 3923
specific use of cosmetics or similar toiletpreparations (3898) 3898
science (3843) 3843
polymorphism (3763) 3763
polymorphism, single nucleotide - genetics (3711) 3711
physiological aspects (3593) 3593
dna sequencing (3472) 3472
nucleotide sequencing (3451) 3451
genetic research (3449) 3449
alleles (3307) 3307
enzymes (3266) 3266
cell biology (3193) 3193
technologies or applications for mitigation or adaptation againstclimate change (3180) 3180
agriculture (3143) 3143
care and treatment (3127) 3127
treatment outcome (3109) 3109
pharmacogenetics (3101) 3101
forestry (3041) 3041
technical subjects covered by former uspc (3038) 3038
hunting (3036) 3036
fishing (3034) 3034
animal husbandry (3032) 3032
trapping (3031) 3031
studies (2995) 2995
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (117) 117
Collection Dvlpm't (Acquisitions) - Vendor file (22) 22
UofT at Mississauga - Stacks (20) 20
Collection Dvlpm't (Acquisitions) - Closed Orders (13) 13
Online Resources - Online (11) 11
Chemistry (A D Allen) - Stacks (10) 10
UofT at Scarborough - Stacks (7) 7
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Cancelled Order (2) 2
Law (Bora Laskin) - Stacks (2) 2
Robarts - Stacks (2) 2
Engineering & Comp. Sci. - Reference (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Periodical Stacks (1) 1
New College (Ivey) - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (79714) 79714
French (11478) 11478
German (5437) 5437
Chinese (2070) 2070
Spanish (849) 849
Japanese (795) 795
Russian (531) 531
Korean (528) 528
Norwegian (467) 467
Portuguese (416) 416
Czech (255) 255
Hungarian (207) 207
Danish (194) 194
Polish (153) 153
Finnish (130) 130
Slovak (114) 114
Slovenian (100) 100
Italian (93) 93
Swedish (84) 84
Hebrew (82) 82
Bulgarian (71) 71
Turkish (63) 63
Serbian (60) 60
Estonian (54) 54
Croatian (52) 52
Icelandic (52) 52
Dutch (51) 51
Ukrainian (48) 48
Greek (28) 28
Lithuanian (21) 21
Romanian (16) 16
Arabic (9) 9
Bosnian (6) 6
Indonesian (2) 2
Latvian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2011, Methods in molecular biology, ISBN 9781617791871, Volume 764., xi, 340
Book
2008, RSC biomolecular sciences, ISBN 0854041168, Volume 12, xvii, 343
This book provides a compelling overall update on current status of RNA interference. 
Therapeutic use | Oligonucleotides | Clinical | Chemistry | SCIENCE | Nucleotides
Book
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, p. CD007419
Background Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti-vascular endothelial growth factor... 
CLINICAL-TRIAL | RANIBIZUMAB PLUS PROMPT | RANDOMIZED CONTROLLED-TRIAL | Receptors, Vascular Endothelial Growth Factor [therapeutic use] | DEFERRED LASER | MEDICINE, GENERAL & INTERNAL | PEGAPTANIB SODIUM | Bevacizumab [adverse effects; therapeutic use] | Laser Coagulation [methods] | Aptamers, Nucleotide [adverse effects; therapeutic use] | Network Meta-Analysis | QUALITY-OF-LIFE | Macular Edema [drug therapy; etiology; surgery] | Vascular Endothelial Growth Factor A [antagonists & inhibitors] | Visual Acuity [drug effects; physiology] | COST-EFFECTIVENESS | Angiogenesis Inhibitors [adverse effects; therapeutic use] | LASER PHOTOCOAGULATION | Randomized Controlled Trials as Topic | Ranibizumab [adverse effects; therapeutic use] | Recombinant Fusion Proteins [adverse effects; therapeutic use] | Quality of Life | INTRAVITREAL BEVACIZUMAB | Diabetic Retinopathy [complications] | Triamcinolone [adverse effects; therapeutic use] | VEGF TRAP-EYE | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Ranibizumab - adverse effects | Visual Acuity - drug effects | Triamcinolone - adverse effects | Laser Coagulation - methods | Angiogenesis Inhibitors - therapeutic use | Angiogenesis Inhibitors - adverse effects | Triamcinolone - therapeutic use | Visual Acuity - physiology | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - adverse effects | Macular Edema - surgery | Macular Edema - drug therapy
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 8, Issue 8, p. CD005139
Journal Article
European Heart Journal, ISSN 0195-668X, 04/2017, Volume 38, Issue 13, pp. 935 - 941d
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations 
CONTROLLED CLINICAL-TRIAL | PROTEIN KINASE-C | PERCUTANEOUS CORONARY INTERVENTION | MITOCHONDRIAL PERMEABILITY TRANSITION | CARDIAC & CARDIOVASCULAR SYSTEMS | NO-REFLOW PHENOMENON | RANDOMIZED CONTROLLED-TRIAL | BYPASS GRAFT-SURGERY | ISCHEMIA-REPERFUSION | LEFT-VENTRICULAR FUNCTION | LONG-TERM BENEFIT | Myocardial Reperfusion Injury - etiology | Nucleotides, Cyclic - metabolism | Ischemic Postconditioning - methods | Vasodilator Agents - therapeutic use | Humans | Oximes - therapeutic use | Nitric Oxide - therapeutic use | Oligopeptides - therapeutic use | Patient Selection | ST Elevation Myocardial Infarction - therapy | Cardiotonic Agents - therapeutic use | Mitochondrial Membrane Transport Proteins - physiology | Adenosine - therapeutic use | Hypothermia, Induced - methods | ST Elevation Myocardial Infarction - complications | ST Elevation Myocardial Infarction - etiology | Coronary Vessels - physiology | Metoprolol - therapeutic use | Combined Modality Therapy | Protein Kinase C - antagonists & inhibitors | Enzyme Inhibitors - therapeutic use | Nitrites - therapeutic use | Cyclosporine - therapeutic use | Myocardial Reperfusion - adverse effects | Signal Transduction - physiology | Clinical Trials as Topic - methods | Nitric Oxide - metabolism | Secosteroids - therapeutic use | Myocardial Reperfusion Injury - prevention & control | Life Sciences | Current Opinion | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 06/2017, Volume 2017, Issue 6, p. CD007419
Background Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti-vascular endothelial growth factor... 
DA VINCI | Macular Edema [drug therapy surgery] | Growth Factor [therapeutic use] | Humans | RANIBIZUMAB PLUS PROMPT | Receptors, Vascular Endothelial | RANDOMIZED CONTROLLED-TRIAL | Bevacizumab | DEFERRED LASER | Antibodies, Monoclonal, Humanized [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Recombinant Fusion Proteins [therapeutic use] | PEGAPTANIB SODIUM | Angiogenesis Inhibitors [therapeutic use] | Laser Coagulation [methods] | Ranibizumab | QUALITY-OF-LIFE | Vascular Endothelial Growth Factor A [antagonists & inhibitors] | COST-EFFECTIVENESS | Triamcinolone [therapeutic use] | LASER PHOTOCOAGULATION | Randomized Controlled Trials as Topic | Antibodies, Monoclonal [therapeutic use] | Aptamers, Nucleotide [therapeutic use] | INTRAVITREAL BEVACIZUMAB | Diabetic Retinopathy [complications] | VEGF TRAP-EYE | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Recombinant Fusion Proteins - therapeutic use | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Ranibizumab - adverse effects | Visual Acuity - drug effects | Triamcinolone - adverse effects | Laser Coagulation - methods | Angiogenesis Inhibitors - therapeutic use | Network Meta-Analysis | Angiogenesis Inhibitors - adverse effects | Triamcinolone - therapeutic use | Visual Acuity - physiology | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - adverse effects | Macular Edema - surgery | Macular Edema - drug therapy | Quality of Life
Journal Article